Janney Montgomery Scott
PCSA icon

Janney Montgomery Scott’s Processa Pharmaceuticals PCSA Stock Holding History

Janney Montgomery Scott’s Portfolio PCSA Stock Details PCSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-92
Closed -$23K – 2701
2023
Q1 		$23K Hold
92
– – ﹤0.01% 2429
2022
Q4 		$51K Hold
92
– – ﹤0.01% 2510
2022
Q3 		$104K Hold
92
– – ﹤0.01% 2405
2022
Q2 		$135K Hold
92
– – ﹤0.01% 2206
2022
Q1 		$139K Hold
92
– – ﹤0.01% 2155
2021
Q4 		$227K Hold
92
– – ﹤0.01% 2164
2021
Q3 		$396K Sell
92
-21
-19% -$71.8K ﹤0.01% 1803
2021
Q2 		$465K Sell
113
-14
-11% -$54.1K ﹤0.01% 1680
2021
Q1 		$690K Sell
127
-6
-5% -$28K ﹤0.01% 1390
2020
Q4 		$437K Buy
+133
New +$369K ﹤0.01% 1657

Other funds holding PCSA

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Janney Montgomery Scott's PCSA Position: Q2 2023 in Review

Janney Montgomery Scott sold out of Processa Pharmaceuticals (PCSA) in Q2 2023, closing a stake of 92 shares — an estimated $23K sold.

Janney Montgomery Scott first reported a position in PCSA in Q4 2020 and held it in 10 quarters. The position peaked at $690K in Q1 2021. 18 funds tracked by Wall St. Rank hold PCSA as of Q2 2023.

  • Janney Montgomery Scott reported no remaining Processa Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 92 Processa Pharmaceuticals shares in Q2 2023, an estimated $23K.
  • Janney Montgomery Scott first reported a position in Processa Pharmaceuticals in Q4 2020 and held it in 10 quarters.
  • Janney Montgomery Scott's Processa Pharmaceuticals position peaked at $690K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q2 2023.

Based on Janney Montgomery Scott's 13F filing for Q2 2023, filed 26 Jul 2023.